Resectable Pancreatic Cancer: Who Really Benefits From Resection?
Resectable Pancreatic Cancer: Who Really Benefits From Resection?
About this item
Full title
Author / Creator
Publisher
New York: Springer-Verlag
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer-Verlag
Subjects
More information
Scope and Contents
Contents
Background
The 1-year disease-related mortality after resection for pancreatic cancer is approximately 30%. This study examined potential preoperative parameters that would help avoid unnecessary surgery.
Methods
Among the patients resected at our institution from 1997 to 2006, a total of 228 underwent pancreatic resection for ductal adeno...
Alternative Titles
Full title
Resectable Pancreatic Cancer: Who Really Benefits From Resection?
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_733884787
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_733884787
Other Identifiers
ISSN
1068-9265
E-ISSN
1534-4681
DOI
10.1245/s10434-009-0670-7
